Benign Prostatic Hyperplasia

Updated Treatment and Prevention Management

Abstract

Background: Benign prostatic hyperplasia (BPH) is a histologic diagnosis which referred to a proliferation of ephitelial and smooth muscle tissues in the transitional zone of the prostate. BPH affects roughly 18-25% of all male aged 40 years and above and 90% of all male aged beyond 80. BPH is known to be able to significantly decrease quality of life and hence people with BPH need treatments to help them alleviate its effects.

Methods: The research was conducted using literature review from the most actual and respected clinical guidelines, scientific literatures, websites, and textbooks on BPH.

Discussion: There are three main groups of treatment, which are conservative, pharmacological, and surgical treatments. Treatment should be chosen from the least invasive first with the aim of increasing quality of life. Even if it is hard to prevent, several preventive measures could be conducted, such as limiting usage of BPH-inducing drugs, doing healthy lifestyle which involves no smoking, active exercise, body weight control, and balanced diet.

Conclusion: BPH is a very prevalent condition on elderly male population. Even though it is not deadly, a proper treatment management need to be done by virtue of its ability to significantly decrease quality of life.